Specialty Pharmaceuticals Market

Specialty Pharmaceuticals Market: Global Industry Analysis and Forecast 2016 - 2024

Specialty Pharmaceuticals Market Segmented By therapeutic area such as Oncology, Inflammatory conditions, Multiple sclerosis, Growth hormone with route of administration such as Oral, Parenteral and Transdermal

Market Overview

Drug molecules that help in treating specific genetic conditions which don’t have any therapeutic intervention in the market are considered to be as specialty pharmaceuticals. Specialty Pharmaceuticals are more targeted drugs and have less toxic in nature when compared with traditional drugs.

Specialty pharmaceuticals include biopharmaceuticals, blood derived products and complex molecules. Pharmaceuticals that are having high cost also falls under the specialty pharmaceuticals. The cost of specialty pharmaceuticals threshold is around $600 per month.

The average cost for specialty medical therapy is around $35,000 to $75,000 costs per patient per year. Specialty pharmaceuticals are mainly available at physician offices in another way these are mostly available through prescriptions. Specialty pharmaceuticals are having the fastest growth in the U.S.

According to a research study, specialty pharmaceuticals drug spending increased in the US by 26.5% in 2014 this is due to the recent launch of drugs for hepatitis C. Specialty pharmaceuticals are gaining traction in the pharma industry is due to lack of proper interventions for few disease conditions and faster regulatory approvals are driving the growth of this market.

In 2014, around 27 specialty pharmaceuticals got U.S regulatory approvals when compared with 24 traditional drug approvals. Companies are also actively involved in developing specialty pharmaceuticals on rare disease conditions to get orphan drug status for their drugs.

In 2015, Europe regulatory authorities approved more medicines for rare diseases around 93 newly approved medicines, and 18 are orphan drugs. Hence, companies are mainly focusing these specialty pharmaceutical owing to their higher revenues and high-profit margins.

For instance, in FY 2014, Teva overall revenue was around $ 20 billion out of that 42% of sales revenue was contributed by the specialty pharmaceutical drugs. Among the specialty pharmaceuticals drugs, Copaxone generated around 50% of the sales revenue.

Based on therapeutic area

 

  • Oncology
  • Inflammatory conditions
  • Multiple sclerosis
  • Growth hormone
  • Other disease conditions
Based on route of administration
  • Oral
  • Parenteral
  • Transdermal
Based on distribution channel
  • Hospitals
  • Retail Pharmacies
  • Specialty Pharmacies
  • Mail Order

Based on therapeutic area, specialty pharmaceuticals market is segmented into oncology, inflammatory conditions, multiple sclerosis and other disease indications. Among them, oncology occupies the major market share followed by inflammatory conditions.

According to WHO, cancers are the leading cause of mortality and morbidity worldwide with an incidence of 14 million cancer cases and 8.2 million cancer-related deaths. In inflammatory disease condition, rheumatoid arthritis occupies the significant market share for the specialty pharmaceuticals when compared with other inflammatory disease conditions.

The higher cost of the drugs is hindering the growth of the specialty pharmaceuticals market. Based on the route of administration, the specialty pharmaceuticals market is segmented into oral, parenteral and transdermal. Parenteral route occupies the major market share followed by the oral route.

On the basis of the distribution channel, specialty pharmaceuticals market is segmented into hospitals, retail, specialty pharmacies and mail order. Hospitals occupy the major pie in the specialty pharmaceutical products this is mainly due to the availability of these drugs over prescription.

Other than hospitals, retail pharmacies, and specialty pharmacies are also have good market share during the forecast period. However, during the forecast period, specialty pharmacies are expected to occupy the major market share when compared with retail pharmacies over the forecast period.

Based on geography, specialty pharmaceuticals market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. North America accounts the significant market share due to high buying power and reimbursement for the specialty pharmaceuticals are the major factors boosting the growth of this market during the forecast period. Asia Pacific specialty pharmaceuticals market is expected to grow over the forecast period owing to the growth of biopharmaceutical industry in China and India.

Major players in the specialty pharmaceuticals market include Teva Pharmaceuticals, Abbvie Inc, Amgen, Johnson & Johnson, Celgene, Gilead Sciences, Roche are the key players in the market. Top 10 U.S specialty pharmaceuticals itself generated around $ 37B revenue in 2012. In U.S specialty pharmaceuticals, Humira is one of the top-selling specialty pharmaceutical drug and it accounted $4.4B in 2012 and expected to dominate the market till 2018.

Find Out More about the Report Coverage

The report covers exhaustive analysis on:

  • Specialty Pharmaceuticals Market Segments
  • Specialty Pharmaceuticals Market Dynamics
  • Historical Actual Market Size, 2013 - 2015
  • Specialty Pharmaceuticals Market Size & Forecast 2016 to 2024
  • Specialty Pharmaceuticals Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Specialty Pharmaceuticals Market Drivers and Restraints

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa 

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance 

Explore Persistence Market Research’s expertise in promulgation of the business !

Recommendations

Post Herpetic Neuralgia Treatment Market

The post herpetic neuralgia treatment market is largely dominated by large vendors who are competing on the basis of market penetration and distribution.Companies, such as Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Endo Pharmaceuticals Inc., hold more than 50% revenue share in the global post herpetic neuralgia treatment market..

Non-infectious Macular Edema Treatment Market

Non Infectious Macular Edema Treatment Market at a CAGR of 7.0% during the forecast period 2018-2026. The study also projects the market to reach a valuation of over US$ 17,200 Mn by the end of 2026..

Precision Medicine Market

Global precision medicine market, estimated to be worth around US$ 56 Bn by 2016 end, is expected to expand at an approximate CAGR of 14% from period of 2016–2024.

Insomnia Treatment Market

Insomnia Treatment Market is projected to register a promising CAGR of 5.2% in terms of value during the forecast period 2018-2026. By the end of 2026, the market will possibly reach over a value worth US$ 7.5 billion..

Our Clients

Our Clients